Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.
暂无分享,去创建一个
Y. Lévy | A. Pollard | J. Lelièvre | R. Thiébaut | M. Snape | O. Launay | E. Clutterbuck | L. Richert | C. Lacabaratz | A. Wiedemann | V. Bockstal | Auguste Gaddah | M. Douoguih | M. Gibani | S. Grande | C. Bétard | N. Goldstein | K. Luhn | Cynthia Robinson | M. Leyssen | C. Robinson | Maarten Leyssen